MNX1 and metastatic malignant neoplasm in the lymph nodes: We showed that patients with high expression of MNX1-AS1 had advanced UICC stage, lymph node metastasis, and poor overall survival (OS) ratio, relative to patients with low expression of MNX1-AS1 (Table 1, Figure 1B).